搜尋
Immatics NV
IMTX添加自選
9.857USD
+0.007+0.07%
收盤 07/02, 13:00（美東）報價延遲15分鐘
1.35B總市值
虧損本益比TTM
股東統計
更新時間: 5月5日 週二
更新時間: 5月5日 週二
持股股東
股東類型
持股股東
持股股東
佔比
T. Rowe Price Investment Management, Inc.
15.70%
DH Capital GmbH & Co. KG
12.59%
Baker Bros. Advisors LP
8.85%
RTW Investments L.P.
8.37%
Suvretta Capital Management, LLC
8.19%
其他
46.31%
持股股東
持股股東
佔比
T. Rowe Price Investment Management, Inc.
15.70%
DH Capital GmbH & Co. KG
12.59%
Baker Bros. Advisors LP
8.85%
RTW Investments L.P.
8.37%
Suvretta Capital Management, LLC
8.19%
其他
46.31%
股東類型
持股股東
佔比
Hedge Fund
23.81%
Investment Advisor
18.54%
Investment Advisor/Hedge Fund
16.81%
Corporation
12.83%
Private Equity
7.76%
Research Firm
5.83%
Individual Investor
5.09%
Venture Capital
2.57%
Endowment Fund
0.52%
其他
6.24%
機構持股
更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q1
191
101.84M
75.94%
-17.43M
2025Q4
194
94.12M
77.43%
-19.50M
2025Q3
196
96.83M
79.67%
-17.44M
2025Q2
213
122.33M
100.64%
-17.23M
2025Q1
214
124.44M
102.37%
-14.20M
2024Q4
208
124.50M
104.31%
+7.71M
2024Q3
202
107.38M
100.53%
-7.52M
2024Q2
201
107.32M
100.55%
-1.74M
2024Q1
188
101.29M
94.78%
+19.35M
2023Q4
166
76.94M
93.30%
+2.21M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
T. Rowe Price Investment Management, Inc.
21.46M
16%
+2.08M
+10.71%
Dec 31, 2025
DH Capital GmbH & Co. KG
17.20M
12.83%
--
--
Jan 31, 2026
Baker Bros. Advisors LP
12.09M
9.02%
--
--
Dec 31, 2025
RTW Investments L.P.
11.43M
8.53%
+2.62M
+29.69%
Dec 31, 2025
Suvretta Capital Management, LLC
11.19M
8.34%
-840.00K
-6.98%
Dec 31, 2025
Perceptive Advisors LLC
10.38M
7.74%
+1.00M
+10.66%
Dec 31, 2025
Vestal Point Capital, LP
6.13M
4.57%
-225.00K
-3.54%
Dec 31, 2025
Jefferies LLC
5.06M
3.77%
+3.86M
+323.42%
Dec 31, 2025
Sofinnova Investments, Inc
3.44M
2.56%
+1.21M
+54.21%
Dec 31, 2025
Morgan Stanley & Co. LLC
2.04M
1.52%
-92.21K
-4.32%
Dec 31, 2025
查看更多
持股ETF
更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Virtus LifeSci Biotech Clinical Trials ETF
1.12%
ALPS Medical Breakthroughs ETF
0.51%
SPDR S&P International Small Cap ETF
0.06%
SPDR Portfolio Developed World ex-US ETF
0.01%
Fidelity Nasdaq Composite Index ETF
0%
Goldman Sachs Innovate Equity ETF
0%
iShares Health Innovation Active ETF
0%
SPDR SSGA US Small Cap Low Volatility Index ETF
0%
State Street SPDR S&P Kensho New Econ Comp ETF
0%
First Trust IPOX Europe Equity Opportunities ETF
0%
Virtus LifeSci Biotech Clinical Trials ETF
佔比1.12%
ALPS Medical Breakthroughs ETF
佔比0.51%
SPDR S&P International Small Cap ETF
佔比0.06%
SPDR Portfolio Developed World ex-US ETF
佔比0.01%
Fidelity Nasdaq Composite Index ETF
佔比0%
Goldman Sachs Innovate Equity ETF
佔比0%
iShares Health Innovation Active ETF
佔比0%
SPDR SSGA US Small Cap Low Volatility Index ETF
佔比0%
State Street SPDR S&P Kensho New Econ Comp ETF
佔比0%
First Trust IPOX Europe Equity Opportunities ETF
佔比0%